{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:29:11Z","timestamp":1793852951717,"version":"4.6.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:00:00Z","timestamp":1740268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:00:00Z","timestamp":1740268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP243fa627009"],"award-info":[{"award-number":["JP243fa627009"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23gm1810004"],"award-info":[{"award-number":["JP23gm1810004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23wm0325047"],"award-info":[{"award-number":["JP23wm0325047"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24wm0325075"],"award-info":[{"award-number":["JP24wm0325075"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP243fa627005"],"award-info":[{"award-number":["JP243fa627005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23wm0325047"],"award-info":[{"award-number":["JP23wm0325047"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22fk0108141"],"award-info":[{"award-number":["JP22fk0108141"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23gm1810004"],"award-info":[{"award-number":["JP23gm1810004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP243fa627005"],"award-info":[{"award-number":["JP243fa627005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01073-5","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T15:19:12Z","timestamp":1740323952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Molecular convergence of neutralizing antibodies in human revealed by repeated rabies vaccination"],"prefix":"10.1038","volume":"10","author":[{"given":"Mizuki","family":"Fujisawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taishi","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2390-4785","authenticated-orcid":false,"given":"Daisuke","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chidchamai","family":"Kewcharoenwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1607-2175","authenticated-orcid":false,"given":"Michihito","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Itakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Yumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnone","family":"Nithichanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Takeoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3820-9542","authenticated-orcid":false,"given":"Tadaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2569-2755","authenticated-orcid":false,"given":"Hirofumi","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6972-585X","authenticated-orcid":false,"given":"Ganjana","family":"Lertmemongkolchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,23]]},"reference":[{"key":"1073_CR1","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1474-4422(13)70038-3","volume":"12","author":"T Hemachudha","year":"2013","unstructured":"Hemachudha, T. et al. Human rabies: neuropathogenesis, diagnosis, and management. Lancet Neurol. 12, 498\u2013513 (2013).","journal-title":"Lancet Neurol."},{"key":"1073_CR2","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1016\/j.vaccine.2018.06.061","volume":"36","author":"World Health Organization","year":"2018","unstructured":"World Health Organization Rabies vaccines: WHO position paper, April 2018\u2014recommendations. Vaccine 36, 5500\u20135503 (2018).","journal-title":"Vaccine"},{"key":"1073_CR3","unstructured":"WHO. Rabies. http:\/\/www.who.int\/health-topics\/rabies (2023)."},{"key":"1073_CR4","first-page":"e50424","volume":"15","author":"P Pattnaik","year":"2023","unstructured":"Pattnaik, P. et al. Alarming rise in global rabies cases calls for urgent attention: current vaccination status and suggested key countermeasures. Cureus 15, e50424 (2023).","journal-title":"Cureus"},{"key":"1073_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1586\/14760584.2015.1011134","volume":"14","author":"A Giesen","year":"2015","unstructured":"Giesen, A., Gniel, D. & Malerczyk, C. 30 years of rabies vaccination with Rabipur: a summary of clinical data and global experience. Expert Rev. Vaccines 14, 351\u2013367 (2015).","journal-title":"Expert Rev. Vaccines"},{"key":"1073_CR6","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(13)62707-5","volume":"384","author":"AR Fooks","year":"2014","unstructured":"Fooks, A. R. et al. Current status of rabies and prospects for elimination. Lancet 384, 1389\u20131399 (2014).","journal-title":"Lancet"},{"key":"1073_CR7","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.vaccine.2021.01.023","volume":"39","author":"C Xu","year":"2021","unstructured":"Xu, C. et al. Immunogenicity after pre- and post-exposure rabies vaccination: a systematic review and dose-response meta-analysis. Vaccine 39, 1044\u20131050 (2021).","journal-title":"Vaccine"},{"key":"1073_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0264-410X(92)90029-J","volume":"10","author":"DJ Briggs","year":"1992","unstructured":"Briggs, D. J. & Schwenke, J. R. Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine. Vaccine 10, 125\u2013129 (1992).","journal-title":"Vaccine"},{"key":"1073_CR9","unstructured":"World Health Organization. The Immunological Basis for Immunization Series: Module 17: Rabies. http:\/\/iris.who.int\/handle\/10665\/259511 (2017)."},{"key":"1073_CR10","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1086\/515267","volume":"177","author":"A Strady","year":"1998","unstructured":"Strady, A. et al. Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy and Pasteur M\u00e9rieux Connaught, purpose and design, which was circulated by the French Caiss. J. Infect. Dis. 177, 1290\u20131295 (1998).","journal-title":"J. Infect. Dis."},{"key":"1073_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.virusres.2016.10.010","volume":"227","author":"RG Dietzgen","year":"2017","unstructured":"Dietzgen, R. G., Kondo, H., Goodin, M. M., Kurath, G. & Vasilakis, N. The family Rhabdoviridae: mono- and bipartite negative-sense RNA viruses with diverse genome organization and common evolutionary origins. Virus Res. 227, 158\u2013170 (2017).","journal-title":"Virus Res."},{"key":"1073_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrmicro2260","volume":"8","author":"MJ Schnell","year":"2010","unstructured":"Schnell, M. J., McGettigan, J. P., Wirblich, C. & Papaneri, A. The cell biology of rabies virus: using stealth to reach the brain. Nat. Rev. Microbiol. 8, 51\u201361 (2010).","journal-title":"Nat. Rev. Microbiol."},{"key":"1073_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/v4010117","volume":"4","author":"AAV Albertini","year":"2012","unstructured":"Albertini, A. A. V., Baquero, E., Ferlin, A. & Gaudin, Y. Molecular and cellular aspects of rhabdovirus entry. Viruses 4, 117\u2013139 (2012).","journal-title":"Viruses"},{"key":"1073_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.chom.2019.12.012","volume":"27","author":"F Yang","year":"2020","unstructured":"Yang, F. et al. Structural analysis of rabies virus glycoprotein reveals pH-dependent conformational changes and interactions with a neutralizing antibody. Cell Host Microbe 27, 441\u2013453.e7 (2020).","journal-title":"Cell Host Microbe"},{"key":"1073_CR15","doi-asserted-by":"publisher","first-page":"101204","DOI":"10.1016\/j.coviro.2022.101204","volume":"53","author":"GD de Melo","year":"2022","unstructured":"de Melo, G. D., Hellert, J., Gupta, R., Corti, D. & Bourhy, H. Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy. Curr. Opin. Virol. 53, 101204 (2022).","journal-title":"Curr. Opin. Virol."},{"key":"1073_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/jvi.62.1.1-7.1988","volume":"62","author":"C Prehaud","year":"1988","unstructured":"Prehaud, C., Coulon, P., LaFay, F., Thiers, C. & Flamand, A. Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. J. Virol. 62, 1\u20137 (1988).","journal-title":"J. Virol."},{"key":"1073_CR17","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1128\/jvi.53.3.926-934.1985","volume":"53","author":"I Seif","year":"1985","unstructured":"Seif, I., Coulon, P., Rollin, P. E. & Flamand, A. Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J. Virol. 53, 926\u2013934 (1985).","journal-title":"J. Virol."},{"key":"1073_CR18","doi-asserted-by":"publisher","first-page":"037","DOI":"10.4172\/jaa.1000061","volume":"5","author":"NA Kuzmina","year":"2013","unstructured":"Kuzmina, N. A., Kuzmin, I. V., Ellison, J. A. & Rupprecht, C. E. Conservation of binding epitopes for Monoclonal Antibodies on the rabies virus glycoprotein. J. Antivir. Antiretrovir 5, 037\u2013043 (2013).","journal-title":"J. Antivir. Antiretrovir"},{"key":"1073_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1099\/jgv.0.000998","volume":"99","author":"JS Evan","year":"2018","unstructured":"Evan, J. S. et al. Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses. J. Gen. Virol. 99, 169\u2013180 (2018).","journal-title":"J. Gen. Virol."},{"key":"1073_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00430-024-00791-2","volume":"213","author":"C Kewcharoenwong","year":"2024","unstructured":"Kewcharoenwong, C. et al. One-dose intradermal rabies booster enhances rabies antibody production and avidity maturation. Med. Microbiol. Immunol. 213, 7 (2024).","journal-title":"Med. Microbiol. Immunol."},{"key":"1073_CR21","unstructured":"WHO. Rabies Vaccines and Immunoglobulins: WHO Position SUMMARY OF 2017 UPDATES. http:\/\/www.who.int\/publications\/i\/item\/WHO-CDS-NTD-NZD-2018.04 (2017)."},{"key":"1073_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.imj.2022.09.003","volume":"1","author":"C Shi","year":"2022","unstructured":"Shi, C. et al. Research progress on neutralizing epitopes and antibodies for the Rabies virus. Infect. Med. 1, 262\u2013271 (2022).","journal-title":"Infect. Med."},{"key":"1073_CR23","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1002\/eji.200526134","volume":"35","author":"RA Kramer","year":"2005","unstructured":"Kramer, R. A. et al. The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries. Eur. J. Immunol. 35, 2131\u20132145 (2005).","journal-title":"Eur. J. Immunol."},{"key":"1073_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.15252\/emmm.201505986","volume":"8","author":"P De Benedictis","year":"2016","unstructured":"De Benedictis, P. et al. Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis. EMBO Mol. Med. 8, 407\u2013421 (2016).","journal-title":"EMBO Mol. Med."},{"key":"1073_CR25","doi-asserted-by":"crossref","unstructured":"M\u00fcller, T. et al. Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans. PLoS Negl. Trop. Dis. 3, e542 (2009).","DOI":"10.1371\/journal.pntd.0000542"},{"key":"1073_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109823","volume":"37","author":"KA Pape","year":"2021","unstructured":"Pape, K. A. et al. High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines. Cell Rep. 37, 109823 (2021).","journal-title":"Cell Rep."},{"key":"1073_CR27","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/ni.3533","volume":"17","author":"AH Ellebedy","year":"2016","unstructured":"Ellebedy, A. H. et al. Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination. Nat. Immunol. 17, 1226\u20131234 (2016).","journal-title":"Nat. Immunol."},{"key":"1073_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.abn8590","volume":"7","author":"R Kotaki","year":"2022","unstructured":"Kotaki, R. et al. SARS-CoV-2 Omicron-neutralizing memory B cells are elicited by two doses of BNT162b2 mRNA vaccine. Sci. Immunol. 7, 1\u201314 (2022).","journal-title":"Sci. Immunol."},{"key":"1073_CR29","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s41590-023-01497-y","volume":"24","author":"Y Zurbuchen","year":"2023","unstructured":"Zurbuchen, Y. et al. Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2. Nat. Immunol. 24, 955\u2013965 (2023).","journal-title":"Nat. Immunol."},{"key":"1073_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.immuni.2017.12.009","volume":"48","author":"KR McCarthy","year":"2018","unstructured":"McCarthy, K. R. et al. Memory B cells that cross-react with group 1 and group 2 Influenza A viruses are abundant in adult human repertoires. Immunity 48, 174\u2013184.e9 (2018).","journal-title":"Immunity"},{"key":"1073_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.virusres.2016.02.002","volume":"215","author":"PD Anindita","year":"2016","unstructured":"Anindita, P. D. et al. Generation of recombinant rabies viruses encoding NanoLuc luciferase for antiviral activity assays. Virus Res. 215, 121\u2013128 (2016).","journal-title":"Virus Res."},{"key":"1073_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41586-022-04778-y","volume":"607","author":"F Muecksch","year":"2022","unstructured":"Muecksch, F. et al. Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost. Nature 607, 128\u2013134 (2022).","journal-title":"Nature"},{"key":"1073_CR33","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41586-022-05609-w","volume":"613","author":"D Schaefer-Babajew","year":"2023","unstructured":"Schaefer-Babajew, D. et al. Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination. Nature 613, 735\u2013742 (2023).","journal-title":"Nature"},{"key":"1073_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08489-3","volume":"10","author":"M Gidoni","year":"2019","unstructured":"Gidoni, M. et al. Mosaic deletion patterns of the human antibody heavy chain gene locus shown by Bayesian haplotyping. Nat. Commun. 10, 628 (2019).","journal-title":"Nat. Commun."},{"key":"1073_CR35","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1016\/S0006-3495(02)75302-2","volume":"83","author":"N Sinha","year":"2002","unstructured":"Sinha, N., Mohan, S., Lipschultz, C. A. & Smith-Gill, S. J. Differences in electrostatic properties at antibody-antigen binding sites: implications for specificity and cross-reactivity. Biophys. J. 83, 2946\u20132968 (2002).","journal-title":"Biophys. J."},{"key":"1073_CR36","doi-asserted-by":"crossref","unstructured":"Lee, J. H., Yin, R., Ofek, G. & Pierce, B. G. Structural features of antibody-peptide recognition. Front. Immunol. 13, 910367 (2022).","DOI":"10.3389\/fimmu.2022.910367"},{"key":"1073_CR37","doi-asserted-by":"crossref","unstructured":"Moriyama, S. et al. Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants. Nat. Commun. 14, 4198 (2023).","DOI":"10.1038\/s41467-023-39890-8"},{"key":"1073_CR38","doi-asserted-by":"publisher","first-page":"11937","DOI":"10.1073\/pnas.0904191106","volume":"106","author":"N Chennamsetty","year":"2009","unstructured":"Chennamsetty, N., Voynov, V., Kayser, V., Helk, B. & Trout, B. L. Design of therapeutic proteins with enhanced stability. Proc. Natl. Acad. Sci. USA 106, 11937\u201311942 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1073_CR39","doi-asserted-by":"crossref","unstructured":"Ruffolo, J. A., Chu, L. S., Mahajan, S. P. & Gray, J. J. Fast, accurate antibody structure prediction from deep learning on massive set of natural antibodies. Nat. Commun. 14, 2389 (2023).","DOI":"10.1038\/s41467-023-38063-x"},{"key":"1073_CR40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.csbj.2023.11.056","volume":"23","author":"AV Madsen","year":"2024","unstructured":"Madsen, A. V. et al. Structural trends in antibody-antigen binding interfaces: a computational analysis of 1833 experimentally determined 3D structures. Comput. Struct. Biotechnol. J. 23, 199\u2013211 (2024).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"1073_CR41","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1093\/bioinformatics\/btw197","volume":"32","author":"D Kuroda","year":"2016","unstructured":"Kuroda, D. & Gray, J. J. Shape complementarity and hydrogen bond preferences in protein-protein interfaces: implications for antibody modeling and protein-protein docking. Bioinformatics 32, 2451\u20132456 (2016).","journal-title":"Bioinformatics"},{"key":"1073_CR42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/jmr.2158","volume":"25","author":"G Raghunathan","year":"2012","unstructured":"Raghunathan, G., Smart, J., Williams, J. & Almagro, J. C. Antigen-binding site anatomy and somatic mutations in antibodies that recognize different types of antigens. J. Mol. Recognit. 25, 103\u2013113 (2012).","journal-title":"J. Mol. Recognit."},{"key":"1073_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0033583500005746","volume":"29","author":"H Nakamura","year":"1996","unstructured":"Nakamura, H. et al. Roles of electrostatic interaction in proteins. Q. Rev. Biophys.29, 1\u201390 (1996).","journal-title":"Q. Rev. Biophys."},{"key":"1073_CR44","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/pro.3280","volume":"27","author":"E Jurrus","year":"2018","unstructured":"Jurrus, E. et al. Improvements to the APBS biomolecular solvation software suite. Protein Sci. 27, 112\u2013128 (2018).","journal-title":"Protein Sci."},{"key":"1073_CR45","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/cid\/ciac288","volume":"75","author":"M Premikha","year":"2022","unstructured":"Premikha, M. et al. Comparative effectiveness of mRNA and inactivated whole-virus vaccines against coronavirus disease 2019 infection and severe disease in Singapore. Clin. Infect. Dis. 75, 1442\u20131445 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"1073_CR46","doi-asserted-by":"publisher","first-page":"e423","DOI":"10.1016\/S2666-5247(21)00177-4","volume":"2","author":"WW Lim","year":"2021","unstructured":"Lim, W. W., Mak, L., Leung, G. M., Cowling, B. J. & Peiris, M. Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19. Lancet Microbe 2, e423 (2021).","journal-title":"Lancet Microbe"},{"key":"1073_CR47","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-04527-1","volume":"604","author":"W Kim","year":"2022","unstructured":"Kim, W. et al. Germinal centre-driven maturation of B cell response to mRNA vaccination. Nature 604, 141\u2013145 (2022).","journal-title":"Nature"},{"key":"1073_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.prevetmed.2021.105555","volume":"199","author":"W Khamduang","year":"2022","unstructured":"Khamduang, W. et al. Antibody response to rabies pre-exposure vaccination among village health volunteers in a northern region of Thailand. Prev. Vet. Med. 199, 105555 (2022).","journal-title":"Prev. Vet. Med."},{"key":"1073_CR49","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","volume":"40","author":"GD Victora","year":"2022","unstructured":"Victora, G. D. & Nussenzweig, M. C. Germinal centers. Annu Rev. Immunol. 40, 413\u2013442 (2022).","journal-title":"Annu Rev. Immunol."},{"key":"1073_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.abg6916","volume":"6","author":"M Sakharkar","year":"2021","unstructured":"Sakharkar, M. et al. Prolonged evolution of the human B cell response to SARS-CoV-2 infection. Sci. Immunol. 6, 1\u201314 (2021).","journal-title":"Sci. Immunol."},{"key":"1073_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq3511","volume":"7","author":"CI Kaku","year":"2022","unstructured":"Kaku, C. I. et al. Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection. Sci. Immunol. 7, eabq3511 (2022).","journal-title":"Sci. Immunol."},{"key":"1073_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-20879-6","volume":"12","author":"WD Harshbarger","year":"2021","unstructured":"Harshbarger, W. D. et al. Unique structural solution from a VH 3-30 antibody targeting the hemagglutinin stem of influenza A viruses. Nat. Commun. 12, 1\u201313 (2021).","journal-title":"Nat. Commun."},{"key":"1073_CR53","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","volume":"584","author":"DF Robbiani","year":"2020","unstructured":"Robbiani, D. F. et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 584, 437\u2013442 (2020).","journal-title":"Nature"},{"key":"1073_CR54","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ni.3460","volume":"17","author":"R Shinnakasu","year":"2016","unstructured":"Shinnakasu, R. et al. Regulated selection of germinal-center cells into the memory B cell compartment. Nat. Immunol. 17, 861\u2013869 (2016).","journal-title":"Nat. Immunol."},{"key":"1073_CR55","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.cell.2020.09.063","volume":"183","author":"C Viant","year":"2020","unstructured":"Viant, C. et al. Antibody affinity shapes the choice between memory and germinal center B cell fates. Cell 183, 1298\u20131311.e11 (2020).","journal-title":"Cell"},{"key":"1073_CR56","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cell.2019.11.032","volume":"180","author":"L Mesin","year":"2020","unstructured":"Mesin, L. et al. Restricted clonality and limited germinal center reentry characterize memory B cell reactivation by boosting. Cell 180, 92\u2013106.e11 (2020).","journal-title":"Cell"},{"key":"1073_CR57","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.4049\/jimmunol.139.12.3996","volume":"139","author":"PR Blier","year":"1987","unstructured":"Blier, P. R. & Bothwell, A. A limited number of B cell lineages generates the heterogeneity of a secondary immune response. J. Immunol. 139, 3996\u20134006 (1987).","journal-title":"J. Immunol."},{"key":"1073_CR58","doi-asserted-by":"publisher","first-page":"12467","DOI":"10.1073\/pnas.0401786101","volume":"101","author":"FA Fellouse","year":"2004","unstructured":"Fellouse, F. A., Wiesmann, C. & Sidhu, S. S. Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. Proc. Natl. Acad. Sci. USA 101, 12467\u201312472 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1073_CR59","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.chom.2022.07.014","volume":"30","author":"WM Ng","year":"2022","unstructured":"Ng, W. M. et al. Structure of trimeric pre-fusion rabies virus glycoprotein in complex with two protective antibodies. Cell Host Microbe 30, 1219\u20131230 (2022).","journal-title":"Cell Host Microbe"},{"key":"1073_CR60","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1016\/j.immuni.2021.08.025","volume":"54","author":"T Onodera","year":"2021","unstructured":"Onodera, T. et al. A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site. Immunity 54, 2385\u20132398.e10 (2021).","journal-title":"Immunity"},{"key":"1073_CR61","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41467-020-14398-7","volume":"11","author":"J Hellert","year":"2020","unstructured":"Hellert, J. et al. Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein. Nat. Commun. 11, 25\u201328 (2020).","journal-title":"Nat. Commun."},{"key":"1073_CR62","doi-asserted-by":"crossref","unstructured":"Nojima, T. et al. In-vitro derived germinal centre B cells differentially generate memory B or plasma cells in vivo. Nat. Commun. 2, 465 (2011).","DOI":"10.1038\/ncomms1475"},{"key":"1073_CR63","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","volume":"329","author":"T Tiller","year":"2008","unstructured":"Tiller, T. et al. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 329, 112\u2013124 (2008).","journal-title":"J. Immunol. Methods"},{"key":"1073_CR64","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0168-1702(97)00080-4","volume":"51","author":"TR Luo","year":"1997","unstructured":"Luo, T. R. et al. A virus-neutralizing epitope on the glycoprotein of rabies virus that contains Trp251 is a linear epitope. Virus Res. 51, 35\u201341 (1997).","journal-title":"Virus Res."},{"key":"1073_CR65","doi-asserted-by":"publisher","first-page":"99","DOI":"10.7883\/yoken.JJID.2018.248","volume":"72","author":"Y Aronthippaitoon","year":"2019","unstructured":"Aronthippaitoon, Y. et al. A cost effective easy competitive enzyme-linked immunosorbent assay suitable for monitoring protective immunity against the rabies virus in the serum of humans and dogs. Jpn J. Infect. Dis. 72, 99\u2013105 (2019).","journal-title":"Jpn J. Infect. Dis."},{"key":"1073_CR66","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/jcc.21287","volume":"30","author":"BR Brooks","year":"2009","unstructured":"Brooks, B. R. et al. CHARMM: the biomolecular simulation program. J. Comput. Chem. 30, 1545\u20131614 (2009).","journal-title":"J. Comput. Chem."},{"key":"1073_CR67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-0716-2609-2_1","volume":"2552","author":"M-P Lefranc","year":"2023","unstructured":"Lefranc, M.-P. & Lefranc, G. Antibody sequence and structure analyses using IMGT\u00ae: 30 years of immunoinformatics. Methods Mol. Biol. 2552, 3\u201359 (2023).","journal-title":"Methods Mol. Biol."},{"key":"1073_CR68","doi-asserted-by":"crossref","unstructured":"Meng, E. C. et al. UCSF ChimeraX: tools for structure building and analysis. Protein Sci. 32, e4792 (2023).","DOI":"10.1002\/pro.4792"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01073-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01073-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01073-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T15:19:16Z","timestamp":1740323956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01073-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,23]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1073"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01073-5","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,23]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}